Sherpa Perfusion™ Cardiac Transport System[1,2]
Currently, the availability of cardiac transplantation is governed by the “ischemic time”, that being, the elapsed time from heart donation to recipient implantation. According to The International Society Of Heart and Lung Transplantation (“ISHLT”) guidelines for the care of heart transplant recipients, the projected ischemic time should not exceed 4 hours,, limiting the distance available to transport a donor heart.
The Sherpa Perfusion™ CTS combines innovative oxygenated perfusion of organs and safe organ storage with the goal of extending ischemic time to 12 hours, significantly altering the transportation range of donor hearts. Sherpa Perfusion™ CTS is designed to be used in conjunction with any of the currently available organ preservation solutions. The Sherpa Perfusion™ CTS is fully disposable, eliminating problems associated with maintenance, device transport and contamination.
 Patents issued and pending.
 This product is not approved for sale.
 ISHLT Guidelines for the Care of Heart Transplant Recipients, Task Force 1: Peri-operative Care of the Heart Transplant Recipient (Aug. 4, 2010)
 J Heart Lung Transplant 2001; 20(2):212.
 J Am Coll Cardiol 2004; 43(9):1553-1561.